Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics and Treatment. This report contains market size and forecasts of Prostate Cancer Diagnostics and Treatment in global, including the following market information:
Global Prostate Cancer Diagnostics and Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Diagnostics and Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biological Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnostics and Treatment include Tolmar, Astellas Pharma, AstraZeneca, Ferring Pharmaceuticals, Johnson & Johnson, Abbott, Sanofi, Ipsen and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Diagnostics and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics and Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, by Type, 2022 (%)
Biological Therapy
Chemotherapy
Global Prostate Cancer Diagnostics and Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Research Institution
Clinic
Global Prostate Cancer Diagnostics and Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnostics and Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Diagnostics and Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Diagnostics and Treatment, market overview.
Chapter 2: Global Prostate Cancer Diagnostics and Treatment market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics and Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Diagnostics and Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics and Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics and Treatment Overall Market Size
2.1 Global Prostate Cancer Diagnostics and Treatment Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Diagnostics and Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics and Treatment Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics and Treatment Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics and Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics and Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Diagnostics and Treatment Market Size Markets, 2022 & 2029
4.1.2 Biological Therapy
4.1.3 Chemotherapy
4.2 By Type - Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Diagnostics and Treatment Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics and Treatment Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Research Institution
5.1.4 Clinic
5.2 By Application - Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnostics and Treatment Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics and Treatment Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnostics and Treatment Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.3.2 US Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.3 France Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.5.2 China Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5.6 India Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
7 Prostate Cancer Diagnostics and Treatment Companies Profiles
7.1 Tolmar
7.1.1 Tolmar Company Summary
7.1.2 Tolmar Business Overview
7.1.3 Tolmar Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.1.4 Tolmar Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.1.5 Tolmar Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.2.4 Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.3.4 AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Ferring Pharmaceuticals
7.4.1 Ferring Pharmaceuticals Company Summary
7.4.2 Ferring Pharmaceuticals Business Overview
7.4.3 Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.4.4 Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.4.5 Ferring Pharmaceuticals Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.5.4 Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.6.4 Abbott Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.7.4 Sanofi Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Ipsen
7.8.1 Ipsen Company Summary
7.8.2 Ipsen Business Overview
7.8.3 Ipsen Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.8.4 Ipsen Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.8.5 Ipsen Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.9.4 Novartis Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Bayer
7.10.1 Bayer Company Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.10.4 Bayer Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.10.5 Bayer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Diagnostics and Treatment Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics and Treatment Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics and Treatment Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics and Treatment in Global Market
Table 5. Top Prostate Cancer Diagnostics and Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Diagnostics and Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Diagnostics and Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Diagnostics and Treatment Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics and Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Tolmar Company Summary
Table 31. Tolmar Prostate Cancer Diagnostics and Treatment Product Offerings
Table 32. Tolmar Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Tolmar Key News & Latest Developments
Table 34. Astellas Pharma Company Summary
Table 35. Astellas Pharma Prostate Cancer Diagnostics and Treatment Product Offerings
Table 36. Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Astellas Pharma Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Prostate Cancer Diagnostics and Treatment Product Offerings
Table 40. AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Ferring Pharmaceuticals Company Summary
Table 43. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Product Offerings
Table 44. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Ferring Pharmaceuticals Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Product Offerings
Table 48. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Abbott Company Summary
Table 51. Abbott Prostate Cancer Diagnostics and Treatment Product Offerings
Table 52. Abbott Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Abbott Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Prostate Cancer Diagnostics and Treatment Product Offerings
Table 56. Sanofi Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Ipsen Company Summary
Table 59. Ipsen Prostate Cancer Diagnostics and Treatment Product Offerings
Table 60. Ipsen Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Ipsen Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Prostate Cancer Diagnostics and Treatment Product Offerings
Table 64. Novartis Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Prostate Cancer Diagnostics and Treatment Product Offerings
Table 68. Bayer Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Bayer Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Diagnostics and Treatment Segment by Type in 2022
Figure 2. Prostate Cancer Diagnostics and Treatment Segment by Application in 2022
Figure 3. Global Prostate Cancer Diagnostics and Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnostics and Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics and Treatment Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Tolmar Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abbott Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Ipsen Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novartis Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bayer Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
